The Matrisome Is Associated with Metabolic Reprograming in Stem-like Phenotypes of Gastric Cancer

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2022 Mar 25

PMID 35326589

Authors

Ji-Yong Sung

Jae-Ho Cheong

Affiliations

Soon will be listed here.

Abstract

The extracellular matrix (ECM) is an important regulator of all cellular functions, and the matrisome represents a major component of the tumor microenvironment. The matrisome is an essential component comprising genes encoding ECM glycoproteins, collagens, and proteoglycans; however, its role in cancer progression and the development of stem-like molecular subtypes in gastric cancer is unknown. We analyzed gastric cancer data from five molecular subtypes ( = 497) and found that metabolic reprograming differs based on the state of the matrisome. Approximately 95% of stem-like cancer type samples of gastric cancer were in the high-matrisome category, and energy metabolism was considerably increased in the high-matrisome group. Particularly, high glycosaminoglycan biosynthesis-chondroitin sulfate metabolic reprograming was associated with an unfavorable prognosis. Glycosaminoglycan biosynthesis-chondroitin sulfate metabolic reprograming may occur according to the matrisome status and contribute to the development of stem-like phenotypes. Our analysis suggests the possibility of precision medicine for anticancer therapies.

Citing Articles

Development of a 23-Gene Signature for Tumor Growth Mechanism in Vestibular Schwannoma.

Sung J, Lee J Cancers (Basel). 2025; 16(24.

PMID: 39766034 PMC: 11674088. DOI: 10.3390/cancers16244134.

Predictive significance of MPT-driven necrosis-related genes signature in gastric cancer and their impact on the tumor microenvironment.

Huang S, Huang L, Jiang Q, Jiang C, Guo G Clin Transl Oncol. 2024; .

PMID: 39690336 DOI: 10.1007/s12094-024-03832-7.

A subtype of cancer-associated fibroblast expressing syndecan-2 (SDC2) predicts survival and immune checkpoint inhibitor response in gastric cancer.

Sung J, Cheong J, Shin K, Kim E Clin Transl Med. 2024; 14(12):e70079.

PMID: 39673118 PMC: 11645442. DOI: 10.1002/ctm2.70079.

Identifying the signature of NAD+ metabolism-related genes for immunotherapy of gastric cancer.

Wen H, Mi Y, Li F, Xue X, Sun X, Zheng P Heliyon. 2024; 10(20):e38823.

PMID: 39640811 PMC: 11620085. DOI: 10.1016/j.heliyon.2024.e38823.

Cancer-Associated Fibroblast Subtypes Reveal Distinct Gene Signatures in the Tumor Immune Microenvironment of Vestibular Schwannoma.

Sung J, Lee J Cells. 2024; 13(19.

PMID: 39404431 PMC: 11475780. DOI: 10.3390/cells13191669.

References

Jurgensen H, Silva L, Krigslund O, van Putten S, Madsen D, Behrendt N . CCL2/MCP-1 signaling drives extracellular matrix turnover by diverse macrophage subsets. Matrix Biol Plus. 2021; 1:100003. PMC: 7852312. DOI: 10.1016/j.mbplus.2019.03.002. View

Walker C, Mojares E, Del Rio Hernandez A . Role of Extracellular Matrix in Development and Cancer Progression. Int J Mol Sci. 2018; 19(10). PMC: 6213383. DOI: 10.3390/ijms19103028. View

Mouw J, Yui Y, Damiano L, Bainer R, Lakins J, Acerbi I . Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression. Nat Med. 2014; 20(4):360-7. PMC: 3981899. DOI: 10.1038/nm.3497. View

Fattet L, Jung H, Matsumoto M, Aubol B, Kumar A, Adams J . Matrix Rigidity Controls Epithelial-Mesenchymal Plasticity and Tumor Metastasis via a Mechanoresponsive EPHA2/LYN Complex. Dev Cell. 2020; 54(3):302-316.e7. PMC: 7423770. DOI: 10.1016/j.devcel.2020.05.031. View

Szklarczyk D, Gable A, Lyon D, Junge A, Wyder S, Huerta-Cepas J . STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2018; 47(D1):D607-D613. PMC: 6323986. DOI: 10.1093/nar/gky1131. View

Hartmann T, Burger J, Glodek A, Fujii N, Burger M . CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells. Oncogene. 2005; 24(27):4462-71. DOI: 10.1038/sj.onc.1208621. View

Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi A, Tanaseichuk O . Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019; 10(1):1523. PMC: 6447622. DOI: 10.1038/s41467-019-09234-6. View

Jarvelainen H, Sainio A, Koulu M, Wight T, Penttinen R . Extracellular matrix molecules: potential targets in pharmacotherapy. Pharmacol Rev. 2009; 61(2):198-223. PMC: 2830117. DOI: 10.1124/pr.109.001289. View

Trojanowska M . Ets factors and regulation of the extracellular matrix. Oncogene. 2001; 19(55):6464-71. DOI: 10.1038/sj.onc.1204043. View

10.

Sung J, Cheong J . Pan-Cancer Analysis Reveals Distinct Metabolic Reprogramming in Different Epithelial-Mesenchymal Transition Activity States. Cancers (Basel). 2021; 13(8). PMC: 8068218. DOI: 10.3390/cancers13081778. View

11.

Cheong J, Yang H, Kim H, Kim W, Kim Y, Kook M . Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis. Lancet Oncol. 2018; 19(5):629-638. DOI: 10.1016/S1470-2045(18)30108-6. View

12.

Paolillo M, Schinelli S . Extracellular Matrix Alterations in Metastatic Processes. Int J Mol Sci. 2019; 20(19). PMC: 6802000. DOI: 10.3390/ijms20194947. View

13.

Nallanthighal S, Heiserman J, Cheon D . The Role of the Extracellular Matrix in Cancer Stemness. Front Cell Dev Biol. 2019; 7:86. PMC: 6624409. DOI: 10.3389/fcell.2019.00086. View

14.

Gordon-Weeks A, Yuzhalin A . Cancer Extracellular Matrix Proteins Regulate Tumour Immunity. Cancers (Basel). 2020; 12(11). PMC: 7696558. DOI: 10.3390/cancers12113331. View

15.

Sung J, Cheong J . New Immunometabolic Strategy Based on Cell Type-Specific Metabolic Reprogramming in the Tumor Immune Microenvironment. Cells. 2022; 11(5). PMC: 8909366. DOI: 10.3390/cells11050768. View

16.

Lim S, Chua M, Yeong J, Tan S, Lim W, Lim C . Pan-cancer analysis connects tumor matrisome to immune response. NPJ Precis Oncol. 2019; 3:15. PMC: 6531473. DOI: 10.1038/s41698-019-0087-0. View

17.

Hershkoviz R, MIRON S, Cohen I, Miller A, Lider O . T lymphocyte adhesion to the fibronectin and laminin components of the extracellular matrix is regulated by the CD4 molecule. Eur J Immunol. 1992; 22(1):7-13. DOI: 10.1002/eji.1830220103. View

18.

Janky R, Verfaillie A, Imrichova H, Van de Sande B, Standaert L, Christiaens V . iRegulon: from a gene list to a gene regulatory network using large motif and track collections. PLoS Comput Biol. 2014; 10(7):e1003731. PMC: 4109854. DOI: 10.1371/journal.pcbi.1003731. View

19.

Cooney C, Jousheghany F, Yao-Borengasser A, Phanavanh B, Gomes T, Kieber-Emmons A . Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells. Breast Cancer Res. 2011; 13(3):R58. PMC: 3218947. DOI: 10.1186/bcr2895. View

20.

Peng X, Chen Z, Farshidfar F, Xu X, Lorenzi P, Wang Y . Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers. Cell Rep. 2018; 23(1):255-269.e4. PMC: 5916795. DOI: 10.1016/j.celrep.2018.03.077. View